Superior in every way....
I'll give you 1 very simple example.
Temcell GvHD 6 months survival 40% (as paper said - UNTIL better survival comes along)
Cymerus GvHD 2 yr survival 60%.
NOTE: in data, patients with extra Liver complications = CR
Your manufacturing is in "the dark ages"
our CEO said so, you know, the one you brazenly chastised for a "non" world first claim, then got published on front page on nature medicine for said "World First".
Deer in the headlights
you're a complete embarrassment to stem cells/ IPSc reality.
Mesoblast in Freefall, page-479
-
- There are more pages in this discussion • 504 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
96.0¢ |
Change
0.025(2.67%) |
Mkt cap ! $1.084B | |||
| Open | High | Low | Value | Volume |
| 95.0¢ | 96.5¢ | 94.0¢ | $1.231M | 1.291M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 94461 | 95.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 96.0¢ | 61151 | 6 |
View Market Depth
| Last trade - 16.10pm 12/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |